These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Heterogeneity in the beta-endorphin immunoreactivity response to electroconvulsive therapy. Young EA; Grunhaus L; Haskett RF; Pande AC; Murphy-Weinberg V; Akil H; Watson SJ Arch Gen Psychiatry; 1991 Jun; 48(6):534-9. PubMed ID: 2039337 [TBL] [Abstract][Full Text] [Related]
6. beta-Endorphin immunoreactivity in the plasma of psychiatric patients receiving electroconvulsive treatment. Inturrisi CE; Alexopoulos G; Lipman R; Foley K; Rossier J Ann N Y Acad Sci; 1982; 398():413-23. PubMed ID: 6297361 [No Abstract] [Full Text] [Related]
7. Corticotropin, cortisol and beta-endorphin responses to the human corticotropin-releasing hormone during melancholia and after unilateral electroconvulsive therapy. Dored G; Stefansson S; d'Elia G; Kågedal B; Karlberg E; Ekman R Acta Psychiatr Scand; 1990 Sep; 82(3):204-9. PubMed ID: 2174200 [TBL] [Abstract][Full Text] [Related]
8. Prolactin and beta-endorphin serum elevations after ECT in manic patients. Chaudhry HR; Hofmann P; Loimer N; Kotter M; Quehenberger F; Fueger G Acta Psychiatr Scand; 2000 Nov; 102(5):386-9. PubMed ID: 11098811 [TBL] [Abstract][Full Text] [Related]
9. Plasma levels of beta-endorphin in depressed patients with and without pain. Daly RJ; Duggan PF; Bracken PJ; Doonan HJ; Kelleher NJ Br J Psychiatry; 1987 Feb; 150():224-7. PubMed ID: 2958101 [TBL] [Abstract][Full Text] [Related]
10. [The effect of a single electroconvulsive shock on pituitary-thyroid-adrenal-gonadal axis function in men with severe depression--preliminary report]. Motta E; Ostrowska Z; Kazibutowska Z; Paluch M; Płonka J; Gołba A Psychiatr Pol; 2005; 39(3):469-79. PubMed ID: 16149757 [TBL] [Abstract][Full Text] [Related]
11. Neuropeptide concentrations in the cerebrospinal fluid of depressed patients treated with electroconvulsive therapy. Corticotrophin-releasing factor, beta-endorphin and somatostatin. Nemeroff CB; Bissette G; Akil H; Fink M Br J Psychiatry; 1991 Jan; 158():59-63. PubMed ID: 1673078 [TBL] [Abstract][Full Text] [Related]
12. Blood serum concentrations of kynurenic acid in patients diagnosed with recurrent depressive disorder, depression in bipolar disorder, and schizoaffective disorder treated with electroconvulsive therapy. Olajossy M; Olajossy B; Wnuk S; Potembska E; Urbańska E Psychiatr Pol; 2017 Jun; 51(3):455-468. PubMed ID: 28866716 [TBL] [Abstract][Full Text] [Related]
13. Plasma pattern of adrenocorticotropin and cortisol during electroconvulsive therapy in patients with major depressive illness. Apéria B; Thorén M; Zettergren M; Wetterberg L Acta Psychiatr Scand; 1984 Oct; 70(4):361-9. PubMed ID: 6093435 [TBL] [Abstract][Full Text] [Related]
14. The effects of electroconvulsive therapy on plasma insulin and glucose in depression. Williams K; Smith J; Glue P; Nutt D Br J Psychiatry; 1992 Jul; 161():94-8. PubMed ID: 1638337 [TBL] [Abstract][Full Text] [Related]
15. Growth hormone and somatomedin serum levels in patients with major depressive illness undergoing electroconvulsive therapy. Apéria B; Thorén M; Undén F; Wetterberg L Acta Psychiatr Scand; 1986 Jun; 73(6):681-7. PubMed ID: 3751671 [TBL] [Abstract][Full Text] [Related]